Search
Now showing items 1-10 of 15
IgG Neutralizing Antibodies to SARS-CoV-2 Among Healthcare Workers Who Frequently Encountered Patients with COVID-19
(2022)
Introduction: Since the Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) first emerged in Wuhan, on 12 December 2019, it has spread rapidly across the world and developed into a pandemic. As healthcare workers ...
Allergen fragrance molecules: a potential relief for COVID-19
(2021)
BackgroundThe latest coronavirus SARS-CoV-2, discovered in China and rapidly spread Worldwide. COVID-19 affected millions of people and killed hundreds of thousands worldwide. There are many ongoing studies investigating ...
Tobacco and COVID-19
(2020)
Tobacco and its products are the well-known causes of premature deaths associated with cancer, cardiovascular disease, and chronic obstructive pulmonary disease, as well as they constitute a significant risk factor that ...
Conjunctivitis as sole symptom of COVID-19: A case report and review of literature
(2020)
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus causing an ongoing pandemic in 2020. Although the symptomatic patients infected by SARS-CoV-2 generally show respiratory distress, ...
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR(-/-) mice
(2020)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently a global pandemic with unprecedented public health, economic and social impact. The development of effective mitigation strategies, therapeutics and ...
SARS-Cov-2 Infection Might Be A Predictor of Mortality in Intracerebral Hemorrhage
(2023)
Background: SARS-CoV-2 infection may be associated with uncommon complications such as intracerebral hemorrhage (ICH), with a high mortality rate. We compared a series of hospitalized ICH cases infected with SARS-CoV-2 ...
Predominant Mutations of SARS-CoV-2: Their Geographical Distribution and Potential Consequences
(2021)
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) emerged in late December 2019 in Wuhan, China. More than 83 million people have been infected, and more than 1.8 million people have died, as reported to the ...
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals
(2021)
It is highly expected that COVID-19 infection will have devastating consequences in sickle cell disease (SCD) patients due to endothelial activation and decreased tissue and organ reserve as a result of microvascular ...
Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic
(2021)
Globally 364102 healthcare professionals have been infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and 1253 of them died until 15 January 2021. Healthcare professionals serving at the forefront ...
Evaluation of the COVID-19 Rapid Antigen Test
(2023)
Introduction: Coronavirus disease, is an infectious disease caused by the SARS-CoV-2. The gold standard method to diagnose is the reverse transcriptase polymerase chain reaction test. Rapid antigen tests can also be used ...